India's Morepen Laboratories rises after unit to form joint venture
** Shares of Morepen Laboratories MORL.NS rise nearly 4% to 50.96 rupees ** Pharma co's subsidiary, Morepen Medipath, to hold 50% stake in JV with Bimedical FZE ** JV will manufacture, trade medical devices-related products ** Trading volume at 4.4 mln shares so far, 1.3x 30-day average ** MORL down ~35% YTD (Reporting by Vijay Malkar) ((VijayDattaram.Malkar@thomsonreuters.com;))
Recent news on Morepen Laboratories
See all newsBrief: Morepen Laboratories Says High Court Quashes Notice Seeking Recovery Of 1.18 Billion Rupees
India's Morepen Laboratories gains on U.S. FDA submission for Sitagliptin tablets
Brief: Morepen Laboratories Submits First U.S. ANDA For Sitagliptin Tablets USP In Three Strengths
Brief: Morepen Laboratories Ltd June-Quarter Consol Net Profit 563.5 Million Rupees
India's Morepen Laboratories slips after quarterly profit fall